Baricitinib CAS 1187594-09-7

Deskripsyon pwodwi:

Non pwodwi: baricitinib CAS NO: 1187594-09-7

 

Sinonim:

2-(3-(4-(7H-pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol{{10 }}il)-1-(ethylsulfonyl)azetidin-3-il)acetonitrile;

{1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pirimidin-4-il)-1H-pirazol -1-il]azetidin-3-il}acetonitrile;

3-Azetidineacetonitrile,1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pirimidin-4-il){{ 9}}H-pirazol-1-il);

 

Pwopriyete chimik ak fizik:

Aparans: Limyè jòn poud

Egzamen: Pi gran pase oswa egal a 99.0%

Dansite: 1.6±0.1 g/cm3

Flash Point: 381.5±35.7 degre

Pwen boulon: 707.2±70.0 degre nan 760 mmHg

Endèks refraktif: 1.763

 

Enfòmasyon sou sekirite:

Mo siyal: Avètisman

Deklarasyon danje: H302

 

Baricitinib se yon inibitè JAK1 ak JAK2 epi yo te itilize kòm yon tretman pwomèt pou atrit rimatoyid.

2-(3-(4-(7H-pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol{{10 }}yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile endike pou tretman atrit rimatoyid modere ak grav nan pasyan adilt ki te reponn ensifizan, oswa ki pa tolere youn oswa plizyè dwòg anti-rimatism ki modifye maladi kòm monoterapi oswa an konbinezon ak methotrexate.

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: baricitinib cas 1187594-09-7, manifaktirè, founisè, faktori, achte, nan stock

• On: Beta-Methyl Vinyl Phosphate (MAP) CAS 90776-59-3
• Pwochen: 1-(4-Nitrophenyl)-2-piperidinone CAS 38560-30-4